Navigation Links
Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
Date:10/17/2007

SWARTZ CREEK, Mich., Oct. 17 /PRNewswire/ -- Diplomat Health Services, in conjunction with McLaren Health Plan, The National Kidney Foundation of Michigan, and corporate sponsor Genzyme, announced today the results of its pilot program for the management of Chronic Kidney Disease (CKD). The program managed chronic kidney disease patients for McLaren Health Plan and showed combined medication and medical cost savings of $300 per patient per month compared to the control group.

Ron Alexander, Vice President of Clinical Services, stated, "This proactive approach proves the effectiveness of our Disease Management Program. We further validated the published savings of $150 per patient per day in delaying the onset of dialysis. Kudos to our staff who received excellent results from our patient satisfaction surveys. Obviously we are very pleased with these results."

The program developed over the course of one year included disease management for Chronic Kidney Disease, Diabetes, and Hypertension. The heart of the CKD Navigator Program is Diplomat's clinical staff who consulted with the patient and their primary care physician to assist in the care of the patient. Medical and prescription cost data was tracked for 6 months and compared to a control group. The program will now be expanded to include additional patients.

Dr. Petroff, Medical Director, McLaren Health Plan stated, "We know disease management programs benefit both patients and healthcare professionals. The results of this CKD pilot program prove that a well-managed CKD disease management program can make a difference in the health of people living with this disease. This data proves that when patients are personally coached or managed, they become more adherent in taking their medication and have a more positive response to therapy."

Maurie Ferriter, Director of Programs and Services at the National Kidney Foundation of Michigan stated, "This shows that this is truly a win - win situation for patients and providers. Providers save money in the management of people with CKD and the individuals with CKD have a better medical outcome and quality of life."

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio- Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home Infusion and operates infusion suites. "With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, FL; Diplomat services the specialty pharmacy needs of patients and physicians nationwide."

For more information contact:

Alecia Greilich - Director of Payor Relations

agreilich@diplomatpharmacy.com

810-720-4451


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Charter and Berbee connect Pharmacy Cooperative
2. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
3. Web-based reporting credited with states top healthcare ranking
4. Visions, Part II: Preizler sees IT leading incremental health system change
5. Visions: Preizler offers insurers perspective on healthcare IT
6. Federal bill would set healthcare IT standards
7. IRS ruling could speed healthcare technology adoption
8. Bill would provide federal aid for healthcare IT
9. Cardinal Health likes growth potential of Viasys NeuroCare Group
10. DHC 2007: Controlling health IT costs the key to capturing value
11. Siemens health services president calls IT benefits unassailable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... have just published their findings on what they believe could be a new ... summary of the new research. Click here to read it now. ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology:
(Date:5/9/2016)... , UAE, May 9, 2016 ... it comes to expanding freedom for high net worth ... Even in today,s globally connected world, there is still ... system could ever duplicate sealing your deal with a ... second passports by taking advantage of citizenship via investment ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
Breaking Biology News(10 mins):